ArticleCell death & disease2017

Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity.

Lihui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.